Literature DB >> 8886412

Mediation by neurotensin-receptors of effects of neurotensin on self-stimulation of the medial prefrontal cortex.

R Fernández1, R Sabater, J A Sáez, R Montes, F Alba, J M Ferrer.   

Abstract

1 Intracortical microinjections of neurotensin (NT) selectively decreased intracranial self-stimulation (ICSS) of the medial prefrontal cortex in the rat. 2 To elucidate whether this effect is mediated by NT receptors or by the formation of NT-dopamine complexes, we investigated the effects on ICSS of intracortical microinjections of neurotensin (1-11), an NT fragment that forms extracellular complexes with dopamine but does not bind to NT receptors. 3 We also studied the effects of the peripheral administration of SR 48692, a selective antagonist of NT receptors, on the inhibition of ICSS produced by the intracortical administration of NT. 4 Unilateral microinjections of neurotensin (1-11) at doses of 10, 20 and 40 nmol into the medial prefrontal cortex did not change the basal ICSS rate of this area. 5 The intraperitoneal administration of SR 48692 at doses of 0.08 and 0.16 mg kg-1 30 min before microinjection of 10 nmol of NT into the medial prefrontal cortex, antagonized the inhibition of ICSS produced by the neuropeptide. 6 These results demonstrate that the inhibitory effect of NT on ICSS is mediated by NT receptors.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8886412      PMCID: PMC1915841          DOI: 10.1111/j.1476-5381.1996.tb15985.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  32 in total

Review 1.  Mesocortical dopamine-neurotensin neurons. Possible opposite role of noradrenergic pathways on heteroregulations of dopamine (D1) and neurotensin postsynaptic receptors in the rat prefrontal cortex.

Authors:  J P Tassin; F Trovero; D Hervé; G Blanc; J Glowinski
Journal:  Ann N Y Acad Sci       Date:  1992       Impact factor: 5.691

Review 2.  The neurobiology of neurotensin: focus on neurotensin-dopamine interactions.

Authors:  J Kasckow; C B Nemeroff
Journal:  Regul Pept       Date:  1991-10-29

3.  SCH 23390 decreases self-stimulation of the medial prefrontal cortex in the rat.

Authors:  R Sabater; J A Saez; J M Ferrer
Journal:  Eur J Pharmacol       Date:  1993-09-28       Impact factor: 4.432

4.  The nonpeptide neurotensin antagonist, SR 48692, used as a tool to reveal putative neurotensin receptor subtypes.

Authors:  I Dubuc; J Costentin; J P Terranova; M C Barnouin; P Soubrié; G Le Fur; W Rostène; P Kitabgi
Journal:  Br J Pharmacol       Date:  1994-06       Impact factor: 8.739

5.  The role of dopamine in maintaining intracranial self-stimulation in the ventral tegmentum, nucleus accumbens, and medial prefrontal cortex.

Authors:  A G Phillips; H C Fibiger
Journal:  Can J Psychol       Date:  1978-06

6.  In vivo and in vitro structure-activity studies with peptide and pseudopeptide neurotensin analogs suggest the existence of distinct central neurotensin receptor subtypes.

Authors:  C Labbé-Jullié; I Dubuc; A Brouard; S Doulut; E Bourdel; D Pelaprat; J Mazella; J Martinez; W Rostène; J Costentin
Journal:  J Pharmacol Exp Ther       Date:  1994-01       Impact factor: 4.030

7.  Neurotensin participates in self-stimulation of the medial prefrontal cortex in the rat.

Authors:  J M Ferrer; R Sabater; J A Saez
Journal:  Eur J Pharmacol       Date:  1993-01-26       Impact factor: 4.432

8.  Biochemical and pharmacological profile of a potent and selective nonpeptide antagonist of the neurotensin receptor.

Authors:  D Gully; M Canton; R Boigegrain; F Jeanjean; J C Molimard; M Poncelet; C Gueudet; M Heaulme; R Leyris; A Brouard
Journal:  Proc Natl Acad Sci U S A       Date:  1993-01-01       Impact factor: 11.205

9.  Neuromedin N decreases self-stimulation of the medial prefrontal cortex.

Authors:  J M Ferrer; R Sabater; J A Sáez
Journal:  Neuroreport       Date:  1992-11       Impact factor: 1.837

10.  Peptidase inhibitors potentiate the effects of neurotensin and neuromedin N on self-stimulation of the medial prefrontal cortex.

Authors:  R Fernández; F Alba; J M Ferrer
Journal:  Neuroreport       Date:  1996-02-29       Impact factor: 1.837

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.